NCT07529847 Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
| NCT ID | NCT07529847 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Asthma (Diagnosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2026-02-28 |
| Primary Completion | 2026-05-15 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
Eligibility Criteria
Inclusion Criteria: * Age between 18-45 years * Both genders (male and female) * Grade 1-3 on mMRC scale of dyspnea * Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020) Exclusion Criteria: * Patients having acute exerbation of COPD/status asthmaticus * Patients diagnosed with acute infection * Patients unable to follow command and instructions * Asthma patients with \>40sec control pause duration
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.